Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹542 Cr₹419 Cr₹1,066 Cr₹921 Cr₹1,218 Cr

What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS is ₹542 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹542 Cr
Mar2024₹419 Cr
Mar2023₹1,066 Cr
Mar2022₹921 Cr
Mar2021₹1,218 Cr

How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹542 Cr
29.25
Mar2024 ₹419 Cr
-60.66
Mar2023 ₹1,066 Cr
15.71
Mar2022 ₹921 Cr
-24.36
Mar2021 ₹1,218 Cr -

Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,893.5 Cr -2% 0.6% -1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,711.0 Cr -0.8% 3.5% 14.7% Stock Analytics
DIVIS LABORATORIES ₹192,376.0 Cr -1% 7.3% 7.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,655.0 Cr -0.9% 10.1% 44.6% Stock Analytics
CIPLA ₹113,979.0 Cr -2.1% -1.8% -6% Stock Analytics
DR REDDYS LABORATORIES ₹96,204.7 Cr -5.8% -13.2% -7.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2%

0.6%

-1%

SENSEX

-2.7%

-0.2%

-8%


You may also like the below Video Courses